Area of research
Genetics · Pathology and Forensic Medicine
Research interest
Research interests include Medicine, Internal medicine, Ibrutinib, Discontinuation, Chemoimmunotherapy, and Comorbidity.
The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI): A Three-Factor Comorbidity Model
Comorbidities predict inferior outcomes in chronic lymphocytic leukemia treated with ibrutinib
Yttrium-90-Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy after Cytoreduction with ESHAP Chemotherapy in Patients with Relapsed Follicular Non-Hodgkin Lymphoma: Final Results of a Phase II Study
Phase 2 Open-Label Study of Bortezomib, Cladribine, and Rituximab in Advanced, Newly Diagnosed, and Relapsed/Refractory Mantle-Cell and Indolent Lymphomas